Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New toothbrush aims to zap gingivitis in one go

NCT ID NCT06561204

Symptom relief Sponsor: University of Minnesota Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a full-mouth electronic toothbrush (FMET) to see if it reduces gum inflammation and plaque better than a regular electronic toothbrush. 94 adults with mild to moderate gingivitis used either the FMET, a conventional electronic toothbrush, or the FMET with a special foam. Researchers measured gum health and plaque levels to compare results.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
full-mouth electronic toothbrush
What this could lead to
If it works, this could point toward a more effective way to reduce gum inflammation and plaque at home.
What could go wrong
This is a small, completed trial with 94 participants. The results may not apply to everyone, and the device may not be significantly better than a regular electronic toothbrush.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

94 people

The number who actually took part.

Started

Dec 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * University of Minnesota School of Dentistry patient of record who is 18 years of age or older. * Documented periodontal classification of mild to moderate gingivitis (\>10% BOP) or documented gingivitis on an intact, reduce, or stable with a history of periodontitis in AxiUm electronic health record (EHR) \>10% BOP. * A minimum of 25% plaque measured O'Leary plaque score. * A minimum of five natural teeth in each quadrant (excluding third molars, dental implants or teeth with more that ½ of natural surface restored). * Be willing to abstain from all professional oral hygiene care (prophy/periodontal maintenance) during the study. * Be willing to abstain from the use of any other dental cleaning aids (dental floss, water flossers, interdental brushes, dental or tooth picks, mouthwash, etc.) during the study. * Access to personal email account and a device connected to the internet to complete questionnaires and communicate with study team. Exclusion Criteria: * Presence of aggressive, necrotizing, uncommon periodontal disease, or any uncontrolled periodontal condition. * Presence of any physical limitation or restriction that might preclude normal oral hygiene procedures (i.e. need another individual to perform oral self-care). * Fixed prosthesis (i.e. implant retained denture), orthodontic appliance or under orthodontic treatment. * Any medication that may impact periodontal conditions (i.e., phenytoin, calcium antagonists, cyclosporin, warfarin, antimicrobials, or steroids). * Have any uncontrolled medical condition or immunocompromised that may impact the study (i.e. uncontrolled diabetes HbA1c \> 7, HIV). * Pregnant, planning to become pregnant, or unsure of pregnancy status (self-reported) * ≥2 weeks of antibiotic use in the past three months. Or antibiotic use in the last six weeks. * Cigarette use within the last year * Unable to comply with the study protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gingivitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gingivitis Plaque, Amyloid

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gingivitis Plaque Toothbrush

Contacts and locations

Locations

  • University of Minnesota School of Dentistry

    Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.